UPDATE: Prolias Sues PDI for Breach of Contract; PDI Denies Liability | GenomeWeb

This article has been updated with a comment from PDI.

NEW YORK (GenomeWeb) – Prolias Technologies today said it has filed a lawsuit against PDI alleging breach of contract, breach of covenant of good faith and fair dealing, intentional interference with contract, and breach of fiduciary duty.  

Prolias, a New York-based molecular diagnostics firm, filed its lawsuit in Superior Court of New Jersey for the County of Morris. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.